eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Meda Pharmaceuticals

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
Telephone: 0845 460 0000
Fax: 0845 460 0002
Medical Information Direct Line: +44 (0)1748 828 810
Medical Information e-mail: meda@professionalinformation.co.uk
Medical Information Fax: +44 (0)1748 828 801
Out of Hours contact: +44 (0)1748 828 810

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 14/10/2009
SPC ZAMADOL 24hr 150 (200/300/400)mg TABLETS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
  • Change to section 5 - Pharmacological Properties
  • Change to section 6.2 - Incompatibilities
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Aug-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Changes to the following sections:
 
1:     addition of 'prolonged release tablets' to the name of the medicinal product
 
2:     lactose monohydrate content added 

4.4:  addition of paragraph relating to lactose

4.5:  interaction of tramadol with ondansetron

4.8:  revised Undesirable Effect table

4.9:  addition of outcome of tramadol overdose

5:     Pharmacotherapeutic group added

6.2:  'Not applicable' added

10:   Date of revision of the SPC text 
Updated on 02/09/2008 and displayed until 14/10/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Date of revision of text on the SPC:   01-Aug-2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided
Updated on 22/09/2005 and displayed until 02/09/2008
Reasons for adding or updating:
  • New SPC for new product
  • SPC Retired pending re-submission

Active Ingredients/Generics

 
  tramadol hydrochloride